Quarterly report · Q3
2934.TEDINET S100T9GJ
Period2023-06-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Amended by S100UXBC (2024-12-11).
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.9bn | 2023-06-01 → 2024-02-29 | Cons. | Net sales |
| Revenue | ¥16.8bn | 2022-06-01 → 2023-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥12.7bn | 2022-06-01 → 2023-02-28 | Cons. | Net sales |
| Operating income | −¥331m | 2023-06-01 → 2024-02-29 | Cons. | Operating income |
| Operating income | −¥718m | 2022-06-01 → 2023-02-28 | Cons. | Operating income |
| Ordinary income | −¥340m | 2023-06-01 → 2024-02-29 | Cons. | Ordinary income |
| Ordinary income | −¥1.8bn | 2022-06-01 → 2023-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥737m | 2022-06-01 → 2023-02-28 | Cons. | Ordinary income |
| Profit before tax | −¥342m | 2023-06-01 → 2024-02-29 | Cons. | Income before income taxes |
| Profit before tax | −¥738m | 2022-06-01 → 2023-02-28 | Cons. | Income before income taxes |
| Net income (owners) | −¥415m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.9bn | 2022-06-01 → 2023-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥615m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent |
| Net income | −¥409m | 2023-06-01 → 2024-02-29 | Cons. | Profit loss |
| Net income | −¥577m | 2022-06-01 → 2023-02-28 | Cons. | Profit loss |
| Total assets | ¥8.7bn | at 2024-02-29 | Cons. | Assets |
| Total assets | ¥7.2bn | at 2023-05-31 | Cons. | Assets |
| Total assets | ¥7.8bn | at 2023-02-28 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥5.7bn | at 2024-02-29 | Cons. | Liabilities |
| Total liabilities | ¥4.5bn | at 2023-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥3.0bn | at 2024-02-29 | Cons. | Net assets |
| Net assets / equity | ¥2.7bn | at 2023-05-31 | Cons. | Net assets |
| Net assets / equity | ¥4.0bn | at 2023-02-28 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.2bn | at 2024-02-29 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2023-05-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥-85.27 | 2023-06-01 → 2024-02-29 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-25.99 | 2023-12-01 → 2024-02-29d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-410.6 | 2022-06-01 → 2023-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-133.6 | 2022-06-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-55.9 | 2022-12-01 → 2023-02-28d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 31.8% | at 2024-02-29 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 34.1% | at 2023-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 48.0% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 37
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-06-01 → 2024-02-29 | −¥172m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-06-01 → 2024-02-29 | −¥172m |
| Reconciling Itemsreconciling | segment profit | 2023-06-01 → 2024-02-29 | −¥438m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥4.7bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥4.6bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue intersegment | 2023-06-01 → 2024-02-29 | ¥165m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥34m |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥3.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥3.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue intersegment | 2023-06-01 → 2024-02-29 | ¥150,000 |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | segment profit | 2023-06-01 → 2024-02-29 | −¥72m |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue | 2023-06-01 → 2024-02-29 | ¥5.3bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue external | 2023-06-01 → 2024-02-29 | ¥5.3bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue intersegment | 2023-06-01 → 2024-02-29 | ¥7m |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | segment profit | 2023-06-01 → 2024-02-29 | ¥146m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2024-02-29 | ¥13.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2024-02-29 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-06-01 → 2024-02-29 | ¥172m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2024-02-29 | ¥107m |
| Reconciling Itemsreconciling | revenue | 2022-06-01 → 2023-02-28 | −¥139m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-06-01 → 2023-02-28 | −¥139m |
| Reconciling Itemsreconciling | segment profit | 2022-06-01 → 2023-02-28 | −¥385m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥4.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥3.9bn |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥139m |
| jpcrp040300-q3r_E33800-000Healthcare Marketing Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥19m |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥3.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥3.0bn |
| jpcrp040300-q3r_E33800-000Healthcare Sales Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | ¥224m |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue external | 2022-06-01 → 2023-02-28 | ¥5.8bn |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥458,000 |
| jpcrp040300-q3r_E33800-000Medical Care Sales Businessreportable segment | segment profit | 2022-06-01 → 2023-02-28 | −¥576m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-06-01 → 2023-02-28 | ¥12.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-06-01 → 2023-02-28 | ¥12.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-06-01 → 2023-02-28 | ¥139m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-06-01 → 2023-02-28 | −¥333m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 352
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人アヴァンティア | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)相 馬 裕 晃 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)橋 本 剛 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 12720969000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 12883930000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 16844572000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | -736761000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | -339778000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | -1841199000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | -615271000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | -414549000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | -1899919000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | -576923000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | -409279000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | -1867423000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 4005294000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 3004666000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 2714794000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 7815117000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 8659929000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 7240548000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | -133.60 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | -85.27 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | -410.60 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.480 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.318 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.341 | |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | -55.90 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | -25.99 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 5134046 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 5137046 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 5134046 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 5137046 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 200100 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 4910100 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 49101 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember | 2798 | |
| Number of shares issued shares voting rights | CurrentQuarterInstant | 5112998 | |
| Number of voting rights issued shares voting rights | CurrentQuarterInstant | 49101 | |
| Number of shares held in own name treasury shares etc | CurrentQuarterInstant_Row1Member | 200100 | |
| Number of shares held in others names treasury shares etc | CurrentQuarterInstant_Row1Member | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |